New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response

Sirada Panupattanapong; Elizabeth B. Brooks

doi:10.3949/ccjm.87a.ccc039

Article Figures & Data

Tables

View popup

TABLE 1

Case definition for Multisystem Inflammatory Syndrome in Children (MIS-C)

An individual < 21 years presenting with

• Fever,^a laboratory evidence of inflammation,^b and evidence of clinically severe illness requiring hospitalization, with multisystem (> 2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological); AND

• No alternative plausible diagnoses; AND

• Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or COVID-19 exposure within the 4 weeks prior to the onset of symptoms

Additional comments

• Some individuals may fulfill full or partial criteria for Kawasaki disease but should be reported if they meet the case definition for MIS-C

• Consider MIS-C in any pediatric death with evidence of SARS-CoV-2 infection

↵a Fever > 38.0°C for ≥ 24 hours, or report of subjective fever lasting ≥ 24 hours.
↵b Including, but not limited to, 1 or more of the following: an elevated C-reactive protein, erythrocyte sedimentation rate, fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase, or interleukin 6, elevated neutrophils, reduced lymphocytes and low albumin.
RT-PCR = reverse transcription polymerase chain reaction
Reproduced from Centers for Disease Control and Prevention website.⁷

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.